November 27, 2013
Celldex Announces Upcoming Presentation at the Deutsche Bank 2013 BioFEST
HAMPTON, N.J., Nov. 27, 2013 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that Anthony Marucci, President and Chief Executive Officer, and Tom Davis, M.D., Senior Vice President and Chief Medical Officer are scheduled to present at the Deutsche Bank 2013 BioFEST on Monday, December 2, 2013 at 9:35 am ET at the Four Seasons Hotel in Boston, MA.
Any chance they have an announcement or just a recap of Pipeline and timeline. HMMMMMMM!!!
Dude, you have been so obviously hoping to pickup shares at lower prices. why not just say it.
Nothing wrong with it, but enough with the game.
Thats about how it is with Celldex, always does it different than most would think. But let's not be too hard on Longs yesterday, it's a painful process, when you have good news and SP gets goofy.
And a bunch of other illnesses for that matter.
Perfect example of respecting nothing. If you think he old, and your elder, you should check your mouth at the door. PUNK!
And when combined with 1127, it may work even better.
The shorts missed the meaning of 1127, and what that means to the value of the entire Celldex pipeline.
What happened Bear? Could it be that investors are starting to figure it out, bit, by bit? And by it, I mean 1127 combined with 110, 011, Avastin, Etc, etc, etc, ect!!!
When they do figure it out, you better not be short.